The Chemours Company
CC
$11.32
-$0.04-0.35%
NYSE
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 136.13% | 123.97% | 231.03% | -167.69% | -141.18% |
Total Depreciation and Amortization | -1.95% | -3.26% | -2.32% | 1.01% | 5.50% |
Total Amortization of Deferred Charges | 33.33% | 50.00% | 22.22% | 11.11% | 0.00% |
Total Other Non-Cash Items | 114.08% | 137.67% | -105.56% | -246.94% | -610.00% |
Change in Net Operating Assets | -269.68% | -290.34% | -357.87% | 601.72% | 701.94% |
Cash from Operations | -213.85% | -222.98% | -173.33% | -38.00% | -26.36% |
Capital Expenditure | 2.70% | -27.81% | -37.50% | -30.48% | -20.52% |
Sale of Property, Plant, and Equipment | -40.00% | -223.81% | -- | 900.00% | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | 762.50% | -- | 762.50% | 762.50% |
Other Investing Activities | 300.00% | -88.24% | 187.50% | -66.67% | -128.57% |
Cash from Investing | -54.15% | -129.27% | 17.91% | 14.02% | 19.37% |
Total Debt Issued | -9.34% | -85.42% | 407.24% | 505.47% | 634.29% |
Total Debt Repaid | -59.79% | 73.77% | -68.10% | -96.53% | -104.32% |
Issuance of Common Stock | -52.63% | -50.00% | 50.00% | -61.70% | -62.75% |
Repurchase of Common Stock | 96.59% | 98.28% | 92.52% | 84.94% | 82.44% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | 0.67% | 0.00% | 1.99% | 1.32% | 3.25% |
Other Financing Activities | 466.67% | 625.00% | -- | -50.00% | -50.00% |
Cash from Financing | -120.93% | -800.00% | 143.86% | 132.92% | 125.07% |
Foreign Exchange rate Adjustments | -650.00% | -54.55% | -1,200.00% | 35.29% | 112.50% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -307.55% | -1,088.61% | 19.11% | 248.21% | 303.64% |